Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800016716Phase 4Recruiting
Phase 4 trial of dexmedetomidine (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Somatosensory evoked potential and Motor evoked potential. Started Jul 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800016716.